Source: Touch Medical Media – ADA Scientific Sessions
Arturo Vegas, Assistant Professor of Chemistry, Boston University Center for Molecular Discovery, Boston, MA, US shares knowledge at ADA 2018 about Nanotechnology and Diabetes Therapy. This information addresses the question: Why is metastatic pancreatic ductal adenocarcinoma (mPDA) so difficult to treat and why are current survival rates so poor compared with other types of cancer?
